recurrent or metastatic - Robuta Search

https://www.nrgoncology.org/Home/News/Post/exploring-the-addition-of-nivolumab-to-platinum-gemcitabine-for-recurrent-or-metastatic-nasopharyngeal-cancer-nrg-hn007/ Exploring the Addition of Nivolumab to Platinum-Gemcitabine for Recurrent or Metastatic... recurrent or metastatic the addition exploring platinum https://www.nccs.com.sg/news/research/dual-immunotherapy-shows-promise-to-treat-recurrent-or-metastatic-nasopharyngeal-cancer Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer recurrent or metastatic nasopharyngeal cancer dual immunotherapy shows https://open.library.emory.edu/concern/publications/7a5b5233-15e7-4b72-a710-f647adb6358e Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck:... Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use recurrent or metastatic squamous cell carcinoma head and neck patients https://www.cancernetwork.com/view/frontline-tislelizumab-chemo-bests-chemotherapy-alone-in-recurrent-or-metastatic-nasopharyngeal-cancer Frontline Tislelizumab/Chemo Bests Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal... May 15, 2026 - Results of the phase 3 RATIONALE-309 trial demonstrate efficacy of tislelizumab added to chemotherapy for recurrent or metastatic nasopharyngeal carcinoma. recurrent or metastatic frontline chemo bests alone https://research.regionh.dk/en/publications/a-non-platinum-regimen-for-the-treatment-of-recurrent-or-metastat/ A Non Platinum Regimen for the Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the... recurrent or metastatic squamous cell carcinoma for the non platinum https://medical-data-models.org/37000 Eligibility Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck... Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck; ODM derived from:... recurrent or metastatic squamous cell carcinoma head and neck eligibility pd https://pure.lib.cgu.edu.tw/en/publications/prognostic-factors-and-risk-stratification-model-of-recurrent-or-/ Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous... recurrent or metastatic risk stratification head neck factors model https://cuk.elsevierpure.com/en/publications/clinical-trial-of-nintedanib-in-patients-with-recurrent-or-metast/ Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the... recurrent or metastatic salivary gland cancer clinical trial nintedanib patients https://app.quri.ai/trials/NCT05445908/skb264-kl-a167-in-recurrent-or-metastatic-her2-negative-brea SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer (NCTNCT05445908) -... Connect with this clinical trial through Quri.ai's free matching service. SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer... recurrent or metastatic breast cancer kl negative https://ega-archive.org/dacs/EGAC00001002295 RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with... RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors recurrent or metastatic rna sequencing gastric cancer tumors patients https://www.ispor.org/vih-articles/Volume-21--Supplemental-S3/PCN268---TREATMENTS-AND-HEALTH-CARE-UTILISATION-(HCU)-IN-PATIENTS-WITH-RECURRENT-OR-METASTATIC-(R-M)-HEAD-AND-NECK-SQUAMOUS-CELL-CARCINOMA-(HNSCC)-FOLLOWING-INITIAL-PLATINUM-THERAPY-IN-THE-UNITED-KINGDOM PCN268 - TREATMENTS AND HEALTH CARE UTILISATION (HCU) IN PATIENTS WITH RECURRENT OR METASTATIC... recurrent or metastatic health care in patients treatments utilisation https://ecancer.org/en/video/7267-keynote048-first-line-pembrolizumab-for-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell... Prof Barbara Burtness speaks with ecancer at ESMO 2018 in Munich about results from a phase III study of pembrolizumab as mono therapy and in combination wit recurrent or metastatic head and neck first line pembrolizumab squamous https://www.marathonofhopecancercentres.ca/our-research/project/dynamic-evaluation-of-liquid-biopsies-in-patients-with-recurrent-or-metastatic-salivary-gland-tumor-histologies-(delish) Dynamic Evaluation of Liquid Biopsies in Patients with Recurrent or Metastatic Salivary Gland Tumor... recurrent or metastatic salivary gland tumor in patients dynamic evaluation https://boa.unimib.it/handle/10281/569660 Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer recurrent or metastatic cervical cancer pembrolizumab persistent https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02358031&r=1 A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous... A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) recurrent or metastatic first line study pembrolizumab mk https://iris.uniupo.it/handle/11579/94838 Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A... recurrent or metastatic salivary gland cisplatin treatment malignancies https://ascopost.com/news/july-2025/camrelizumab-plus-famitinib-vs-camrelizumab-alone-in-recurrent-or-metastatic-cervical-cancer/ Camrelizumab Plus Famitinib vs Camrelizumab Alone in Recurrent or Metastatic Cervical Cancer - The... In a Chinese phase II trial reported in the Journal of Clinical Oncology, Xia et al compared the objective response rate of camrelizumab plus famitinib vs... recurrent or metastatic cervical cancer plus vs alone https://eguideline.guidelinecentral.com/i/1475485-noncastrate-advanced-recurrent-or-metastatic-prostate-cancer-initial-management ASCO GUIDELINES Bundle - Noncastrate Advanced, Recurrent or Metastatic Prostate Cancer Initial... ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com.... recurrent or metastatic prostate cancer asco guidelines bundle https://ar.iiarjournals.org/keyword/recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma recurrent or metastatic head and neck squamous cell carcinoma | Anticancer Research recurrent or metastatic head and neck squamous cell carcinoma anticancer research https://expertise.unibs.it/resource/item/130128?language=en-US UNIFIND - UNIBS - Prognostic and predictive factors in recurrent and/or metastatic head and neck... Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and... recurrent or metastatic head neck predictive factors https://repository.icr.ac.uk/items/ecf4821f-f467-463c-b458-73fbb4e87f0e Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell... PURPOSE: The phase III KEYNOTE-048 (ClinicalTrials.gov identifier: NCT02358031) trial of pembrolizumab in recurrent or metastatic (R/M) head and neck squamous... head and neck pembrolizumab alone chemotherapy recurrent